Common Contracts
5 similar null contracts by Biosphere Medical Inc, Incara Inc, Incara Pharmaceuticals Corp
ContractBiosphere Medical Inc • November 15th, 2004 • Pharmaceutical preparations • New York
THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE ACT AND ANY OTHER APPLICABLE SECURITIES LAWS, OR (2) AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.
ContractBiosphere Medical Inc • November 15th, 2004 • Pharmaceutical preparations • New York
THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE ACT AND ANY OTHER APPLICABLE SECURITIES LAWS, OR (2) AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.
INCARA PHARMACEUTICALS CORPORATION WARRANT TO PURCHASE 12,500,000 SHARES OF COMMON STOCKIncara Pharmaceuticals Corp • January 15th, 2004 • Pharmaceutical preparations • New York
For value received, Incara Pharmaceuticals Corporation (f/k/a Incara, Inc.), a Delaware corporation (the “Company”), hereby certifies that Goodnow Capital, L.L.C., or its registered transferees, successors or assigns (each person or entity holding all or part of this Warrant being referred to as a “Holder”), is the registered holder of warrants (the “Warrants”) to subscribe for and purchase Twelve Million Five Hundred Thousand (12,500,000) shares (as adjusted pursuant to the next paragraph and Section 3 hereof, the “Warrant Shares”) of the fully paid and nonassessable common stock, par value $0.001 per share (the “Common Stock”), of the Company at any time on or prior to the Expiration Date (as defined below) at a purchase price per share initially equal to Forty Cents ($0.40) (the “Warrant Price”), subject to the provisions and upon the terms and conditions hereinafter set forth. For purposes of this Warrant, “Expiration Date” shall mean 5:00 P.M., Eastern Time, on January 9, 2006, un
INCARA PHARMACEUTICALS CORPORATION WARRANT TO PURCHASE 50,000,000 SHARES OF COMMON STOCKIncara Inc • September 19th, 2003 • New York
This Warrant, together with the Company Warrant, are the Warrants referred to in that certain Debenture and Warrant Purchase Agreement (the “Purchase Agreement”; capitalized terms not expressly defined herein shall have the meaning assigned to such terms in the Purchase Agreement), dated as of September 16, 2003, by and among the Company, Incara, Inc., a Delaware corporation and\ a wholly owned subsidiary of the Company (“Incara Sub”), and the initial Holder. The number of Warrant Shares then purchasable hereunder shall be reduced, share for share, by the number of shares of Company Common Stock that are actually upon (i) exercise of the Company Warrant and (ii) conversion of the Debenture.
INCARA, INC. WARRANT TO PURCHASE 50,000,000 SHARES OF COMMON STOCKIncara Inc • September 19th, 2003 • New York
This Warrant, together with the Parent Warrant, are the Warrants referred to in that certain Debenture and Warrant Purchase Agreement (the “Purchase Agreement”; capitalized terms not expressly defined herein shall have the meaning assigned to such terms in the Purchase Agreement), dated as of September 16, 2003, by and among the Company, the Parent and the initial Holder. The number of Warrant Shares issuable upon exercise of this Warrant shall be reduced, share for share, by the number of (i) shares of Parent Common Stock that are actually issued upon exercise of the Parent Warrant and (ii) shares of Common Stock of the Company that are actually issued upon conversion of the Debenture.
